| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich short-term glucose claim is being checked?Required |
The selected claim is lower acute or several-day postprandial glucose, originally graded C, with a note that two small studies reported positive signals. Absent subclaim score/status is distinguished from parent C50 and uncertain long-term benefit. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Selected acute or several-day postprandial glucose claim |
Material needed: Material for the selected question's postprandial measures, times, direct comparisons and populations, plus boundary review. Do not fill the subclaim score from its parent. This records needed materials; no new research was executed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionWhat did the acute 15-person trial report for glucose?Required |
Jakubowicz's randomized crossover trial in 15 participants used 50 g whey 30 minutes before a meal. Preserve the original 28% lower 180-minute glucose response; do not transfer this into a glucose concentration at a specific time or an absolute between-condition effect/CI. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original estimate of 180-minute glucose response |
Material needed: The definition of the 180-minute response, original curves/measures, direct comparator, absolute effect/CI, exact P value and analysis denominator. No new absolute effect or numerical example is calculated from 28%. This records needed materials; no new research was executed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionAre insulin and GLP-1 the same outcomes as glucose or complications?Required |
The key report records glucose 28% lower and insulin 105% higher, with a GLP-1 increase. Insulin and GLP-1 are mechanistic outcomes; an exact GLP-1 value is not established by this summary. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Separate mechanistic hormones from postprandial glucose |
Material needed: Each hormone's times, denominators, effects/CIs and actual clinical outcomes. Do not transfer 105% into glucose reduction or complication prevention. This records needed materials; no new research was executed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat was the 7-day free-living iAUC result?Required |
In Smith's free-living crossover trial with 18 participants, iAUC was 1.6±0.6 versus 2.1±0.9, P=.003. Do not invent unrecorded units, between-condition differences, CIs or the meaning of ±. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Smith's 7-day postprandial glucose iAUC |
Material needed: iAUC units/baseline, curve interval, analysis, direct between-condition CI, the type of ± statistic, period-specific denominators and missing data. This records needed materials; no new research was executed. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionAre time above range and iAUC distinct outcomes?Required |
Smith's endpoint description lists postprandial glucose iAUC and time above range; the citation title mentions increased time in euglycemia. Exact time changes, range thresholds and outcome-specific effects/CIs are not established by this summary. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Separate time above range, time in euglycemia and postprandial iAUC |
Material needed: Definitions of high/normal glucose ranges, valid CGM time, missing data, outcome-specific effects/CIs and prespecified hierarchy. Do not copy iAUC P=.003 to other time metrics. This records needed materials; no new research was executed. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionAre acute 180-minute and 7-day measures the same time point?Required |
The acute 180-minute and 7-day free-living studies have different times and designs. Parent duration is 180 minutes after a single meal; do not copy this to every 7-day outcome or long-term follow-up. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Time boundaries for one-meal response and several-day free-living exposure |
Material needed: Report-specific time origins, meal/measurement windows, repeats, period-specific analysis denominators and post-intervention material. Do not turn short-term reduction into long-term HbA1c benefit. This records needed materials; no new research was executed. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionWere the formulation and protein amount the same?Required |
The parent records acute 50 g and a premeal 15.6 g protein drink. Do not turn 15.6 g into total drink volume, an effective dose for all whey products or a long-term whey-only formulation. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Acute 50 g whey and a 15.6 g protein drink |
Material needed: Report-specific product/ingredient, protein content, manufacturing/formulation, comparator and actual exposure material. No new dose/total calculations or dosing instructions. This records needed materials; no new research was executed. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionWas the 7-day comparator isocaloric?Required |
Stored wording states approximately 100 kcal for the 7-day test drink and approximately 34 kcal for control, with a non-isocaloric comparison. This does not certify an isolated protein effect at equal calories. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Calories and nutritional composition of test/control drinks |
Material needed: Test/control composition, calories, taste/blinding, meal compensation, total intake and activity changes. No new calorie difference or cumulative calories are calculated. This records needed materials; no new research was executed. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionAre preload timing and meal conditions linked?Required |
The parent ingredient wording is preload 10–30 minutes before meals; the key acute trial used 30 minutes before a meal. Identical meals and detailed postprandial measurement/comparator conditions for each report remain separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Preload timing and meal/comparator conditions |
Material needed: Report-specific meal/preload times, meal composition, control procedures, measurement and adherence source material. Preserve research identifiers without creating an intake sequence or dosing instructions. This records needed materials; no new research was executed. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionWere participants and glucose-lowering medications comparable?Required |
The key study concerns 15 adults with type 2 diabetes, and the parent research description records non-insulin-treated adults. Study-specific baseline medication, renal/complication status, HbA1c and glucose details are unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Type 2 diabetes and non-insulin-treated population boundaries |
Material needed: Report-specific eligibility, baseline characteristics and medication/meal cointerventions. Do not establish effects in insulin-treated or other populations, or give medication-change instructions. This records needed materials; no new research was executed. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionAre original crossover denominators and period effects known?Required |
Original sample sizes are 15 and 18 and both short-term studies use crossover designs. Sequence, washout, carryover, period effects, missing data/analysis denominators and measurement counts for every meal remain separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Crossover design, repeated measurements and denominators for 15/18 participants |
Material needed: Allocation sequence, period-specific analysis populations, attrition, repeated-measures models and missing-measurement source material. Do not count repeats in the same people as new participants or independent trials. This records needed materials; no new research was executed. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionDid registered and published primary outcomes agree?Required |
The parent records a mismatch between the registered primary outcome and the published primary outcome in Smith, with a prespecified-hierarchy concern. ISRCTN17563146 alone does not establish which endpoints/times differed in this work. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Historical Smith registered/published outcome-hierarchy mismatch |
Material needed: Registration dates/change history, protocol/SAP, original published outcome wording and the exact mismatch. Preserve the historical mismatch without new registry verification or regrading. This records needed materials; no new research was executed. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionIs null primary iAUC for MCT plus WPI a whey-only result?Required |
Zameer 2025 is an MCT-plus-WPI crossover trial recording null primary 24-hour/daytime glucose iAUC. Do not substitute it for the same formulation or a direct contrary effect in the short-term whey-only question. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
24-hour/daytime endpoints of combined MCT plus WPI |
Material needed: Product/components, comparator, duration, population/denominators, each primary iAUC effect/CI and exact P value. Null findings do not create equivalence, zero effect or a whey-only conclusion. This records needed materials; no new research was executed. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionIs the longer whey-plus-guar report identified?Required |
The parent mentions whey plus guar in longer-term material, but the current three evidence/citation reports do not separately identify that guar report's bibliography, duration, denominator or effect. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Combined long-term material versus whey-only/report identification |
Material needed: The original guar-combination bibliography, components, duration, results, denominators and isolated contribution. Do not create trial, participant or effect numbers for an unidentified report. This records needed materials; no new research was executed. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionDo short-term glucose findings establish long-term HbA1c or complications?Required |
The other existing subclaim grades long-term whey-only HbA1c/complication benefit ? and notes combination interventions in longer trials. Do not transfer short-term glucose, insulin or GLP-1 changes into those clinical outcomes or medication reduction. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Postprandial surrogates, long-term whey-only benefit and medication-replacement boundaries |
Material needed: Direct long-term whey-only HbA1c, clinical-complication and medication outcomes, comparisons/CIs and denominators. No new diabetes-treatment/medication-replacement conclusions or instructions. This records needed materials; no new research was executed. |
| 16 |
Unverified |
Full text not readStored summary read |
N16 · Evidence conditionDo unverified effects/CIs and statistical units remain explicit?Required |
Retain original scope for 28% glucose response, 105% insulin, and iAUC 1.6±0.6 versus 2.1±0.9/P=.003. Units, the meaning of ±, absolute between-condition effects/CIs and exact P values for each comparison are not all supplied at the same level. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Distinguish relative response, iAUC, ± values and denominators |
Material needed: Original tables, models, units, variance definitions, CIs and measurement times/denominators for each outcome. No invented numbers, new effects/intervals or unit conversions. This records needed materials; no new research was executed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionDoes the same direction establish strict independent replication?Required |
The parent's counterview records supporting postprandial direction in different short designs while retaining small-sample, industry, calorie and combination limitations. Preserve parent R1/I0 without certifying new independent replication. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Short-term designs, industry involvement and combination differences |
Material needed: Independent studies addressing the same question, formulation, calories/comparator, population and prespecified outcomes, plus funding/analysis roles. No new pooled effect, unique-trial count or participant total. This records needed materials; no new research was executed. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionAre shared reports/populations counted as new independent trials?Required |
Parent 2997 and existing subclaims share the context of the same three reports. Sheet/report counts, crossover periods, subgroups and repeated measurements are not summed into new independent trials or participants. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Shared parent, subclaim, report and cohort relationships |
Material needed: Original study/report identities, cohorts and analysis-population links. Unique-trial and unique-participant totals are unverified. This records needed materials; no new research was executed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionWhich materials were actually read?Required |
The complete parent summary is read for production and preserved as a complete byte copy. External abstracts, full texts, registration and protocols/SAPs are unread. URLs, PMCIDs or registration identifiers do not establish actual reading or successful access. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Stored parent summary versus external access |
Material needed: Actually acquired original papers, supplements, registration/plans and reading records. No separate external link/screen tests or new lookup. This records needed materials; no new research was executed. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionWhere are original bibliography and registry identifiers recorded?Required |
Link original citation PMIDs, PMCIDs, DOIs and PubMed URLs unchanged. Preserve evidence NCT/ISRCTN wording separately from absent registration wording in citations. No new registry URLs are inferred from identifiers. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Evidence registration field versus citation bibliography |
Material needed: Paper-registry identity, dates and content. A registration identifier does not prove prospective status or actual reading. This records needed materials; no new research was executed. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionWhat is the scope of historical verification wording?Required |
Preserve selected claim/note, parent Korean/English, historical cross-check wording and citation statements that findings were checked. This work prepares materials; review of existing content and claim boundaries remains incomplete. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original Korean/English, subclaim notes and historical cross-check wording |
Material needed: Review of originals, translation and corrections. Do not label historical verification as a new completed clinical review or independent clinical validation. This records needed materials; no new research was executed. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionAre selected-subclaim values separate from parent score and axes?Required |
Preserve original selected grade/note and leave absent subclaim score/status unrecorded. Parent C50/Caution and all axes, including unrecorded precision, remain parent context and do not fill the selected short-term glucose score/axes or certify independence. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original subclaim grade/note, absent score/status and parent context |
Material needed: Review of the selected question, original values and parent boundary. No new scores, axes, efficacy grades or verdict changes. This records needed materials; no new research was executed. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionWhat are the original evidence date and empty correction history?Required |
Original evidence date is 2026-09-07, corrections are an empty list and deliberation is an empty string. Distinguish these from production/review dates without certifying absence of external corrections. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Separate evidence date, corrections and production date |
Material needed: Actual corrections/follow-up material and original/change records when acquired. Existing wording and dates are preserved. This records needed materials; no new research was executed. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionAre funding, product support, employee authors and analysis roles distinguished?Required |
Jakubowicz records health-ministry/Milk Council support, Smith product/industry support and investigator involvement, and Zameer mixed academic/product-related support. Investigator involvement does not automatically establish employee authorship; analysis/reporting roles and product-support details remain separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Four report-specific industry/support aspects |
Material needed: Each report's original funding, product/device support, author affiliations and analysis/publication roles. Do not upgrade parent independence axes into new certification. This records needed materials; no new research was executed. |
| 25 |
Unverified |
Full text not readStored summary read |
N25 · Evidence conditionAre allocation, blinding, measurement and selective reporting known?Required |
Preserve crossover design, calorie imbalance and outcome-hierarchy issues. Allocation concealment, sequence/period effects, blinding, CGM/glucose measurement, missing data and selective-reporting details remain separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Original study designs and detailed bias conditions |
Material needed: Methods, registration/protocol/SAP, original analysis tables and change history. A design label does not establish official RoB/GRADE certification or completed review. This records needed materials; no new research was executed. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionAre adherence, cointerventions and actual exposure preserved?Required |
Preserve original premeal formulation/content, calorie imbalance and combinations as research identifiers. Actual intake adherence, other meals, medication and total-exposure details remain unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Actual intervention, control and shared management by report |
Material needed: Original cointervention, adherence, exposure and intervention-deviation material. No new totals/repetition counts, cumulative-exposure calculations or dosing instructions. This records needed materials; no new research was executed. |
| 27 |
Unverified |
Full text not readStored summary read |
N27 · Evidence conditionAre original safety cautions separate from actual harm collection?Supplementary |
Parent safety wording concerning milk-protein allergy and glucose-lowering medication/meal changes is original context. Actual allergy/hypoglycemia event counts, collection methods, arm-specific exposure denominators and CIs remain separately unverified. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Harm definitions, collection, comparators and exposure denominators |
Material needed: Report-specific harm definitions, collection, severity, exposure/denominators, attrition and shared management. Do not turn original cautions into no-harm claims, new safety certification or treatment instructions. This records needed materials; no new research was executed. |
| 28 |
Unverified |
Full text not readStored summary read |
N28 · Evidence conditionAre long-term/rare harms and post-intervention outcomes available?Supplementary |
Acute/7-day glucose signals and combination context do not establish long-term whey-only effects or rare allergy/hypoglycemia incidence. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Short-term scope versus long-term/rare harms |
Material needed: Actual long-term/harm follow-up, exposure duration, outcome-specific denominators and report links. Unread/unverified is not zero events or established safety. This records needed materials; no new research was executed. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionWhich new materials would prompt an update to this table?Required |
This is a production table from stored material for short-term postprandial glucose. Rows and links can be updated after original papers, endpoints/times, denominators, actual comparators, shared reports and support/harm material are reviewed. |
The selected claim, parent material and reports are distinguished and transferred from the stored summary. Detailed original material is unverified and review of existing content remains incomplete. This does not establish completed clinical review or certification. |
Conditions, observations, original material and verdict-change events |
Material needed: Complete prechange preservation, original materials, condition versions, separate application and review records. No new searches, calculations, grades, independence certification, dosing instructions, medication changes or treatment guidance. This records needed materials; no new research was executed. |